{
    "title": "Gilead's remdesivir set to become Europe's first COVID-19 therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8459569/Gileads-remdesivir-endorsed-COVID-19-treatment-Europe.html",
    "date": "2020-06-25",
    "keywords": [
        "drug",
        "remdesivir",
        "treatment",
        "gilead",
        "price",
        "aripaka",
        "europe",
        "agency",
        "ema",
        "year",
        "approval",
        "june",
        "healthcare",
        "track",
        "therapy",
        "disease",
        "continent",
        "thursday",
        "committee",
        "chmp",
        "age",
        "pneumonia",
        "oxygen",
        "support",
        "union",
        "marketing",
        "authorisation",
        "bloc",
        "efficacy",
        "data",
        "endorsement",
        "commission",
        "executive",
        "formality",
        "week",
        "research",
        "group",
        "course",
        "statement",
        "demand",
        "covid19",
        "promise",
        "supply",
        "issue",
        "italys",
        "level",
        "situation",
        "one",
        "eu",
        "quantity",
        "procurement",
        "office",
        "veklury",
        "yearend",
        "double",
        "target",
        "drugmaker",
        "easiertouse",
        "version",
        "coronavirus",
        "bodys",
        "immune",
        "system",
        "ebola",
        "emergency",
        "use",
        "severelyill",
        "korea",
        "japan",
        "pushkala",
        "reporting",
        "parodi",
        "skydsgaard",
        "editing",
        "koyyur",
        "barbara",
        "sitholematarise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}